MAP1LC3A and glioblastoma: Giatromanolaki et al. (2014) reported that the overexpression of MAP1LC3A was correlated with impaired autophagic degradation activity, which may facilitate the carcinogenesis of glioblastoma. In addition, another study showed that the MAP1LC3A expression at the surgical margins could be a poor biomarker for clinical prognosis in oral squamous cell carcinoma (Terabe et al., 2018).